Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about FDA grant accelerated approval for Darzalex for patients with previously treated multiple myeloma
U.S. Food and Drug Administration granted accelerated approval for Darzalex (daratumumab) to treat patients with multiple myeloma who have received at least three prior treatments. Darzalex is the first monoclonal antibody approved for treating multiple myeloma. Darzalex is marketed by Janssen Biotech of Horsham, Pennsylvania.
- Read more about Coherus, Baxalta announce CHS-0214 meets primary endpoint in phase 3 psoriasis study
Coherus BioSciences and Baxalta has recently announced that CHS-0214, a proposed biosimilar of Enbrel (etanercept), met its primary endpoints in a confirmatory, double-blind, randomized, controlled, two-part phase 3 study. This on-going 52-week study is evaluating the efficacy and safety of CHS-0214 compared to Enbrel in patients with moderate-to-severe chronic plaque psoriasis. Coherus and Baxalta initiated a collaboration to develop and commercialise CHS-0214 in September of 2013.
- Read more about TCS delivers SAP Transformation for Australian Pharmaceutical Industries
Tata Consultancy Services, a leading IT services, consulting and business solutions firm, today announced the go-live of a comprehensive IT and business transformation program for Australian Pharmaceutical Industries (API), a leading Australian health and beauty company.

[adsense:336x280:8701650588]
- Read more about Child with drug-resistant TB treated successfully in US
A team of specialists at Johns Hopkins Children's Centre, including one of Indian origin, has successfully treated a child with a highly virulent form of tuberculosis known as XDR TB, or extensively drug-resistant TB.
- Read more about Inexpensive one-step test for hepatitis C infection
Researchers have developed a cost-effective one-step test that can screen, detect and confirm hepatitis C virus (HCV) infections from blood or urine samples. Current blood-based HCV testing requires two steps and can be expensive, inconvenient and is not widely available or affordable globally.
- Read more about Pharmacy selling cancer drugs at heavy discount opened
Union Health Minister J.P. Nadda on Sunday inaugurated India's first retail facility at AIIMS to provide drugs for cancer and cardiovascular diseases at highly discounted rates.
- Read more about Lead exposure hampers children's sleep quality
Lead exposure in early in life is associated with increased risk of sleep problems and excessive daytime sleepiness in later childhood, says a new study.
- Read more about Drug that could limit spread of deadly brain tumours
Researchers have identified a drug that works to limit the spread of glioblastoma, the most common primary tumour of the brain and central nervous system which is also regarded as one of the most aggressive of all cancers.
- Read more about Human Eye's blind spot can shrink with training
The blind spot of the human eye can be shrunk with certain eye-training exercises, thus improving a person's vision slightly, a new study has found. The human eye includes an unavoidable blind spot. That is because the optic nerve that sends visual signals to the brain must pass through the retina, which creates a hole in that light-sensitive layer of tissue.
- Read more about FDA grants approval for Tagrisso (AZD9291) to treat patients with EGFR T790M mutation-positive metastatic non-small cell lung cancer
AstraZeneca announced that the US Food and Drug Administration (FDA) has approved TAGRISSO (AZD9291) 80mg once-daily tablets for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, who have progressed on or after EGFR tyrosine kinase inhibitor (TKI) therapy.